No Data
No Data
In 2025, US Biotech stocks are expected to rise significantly. jpmorgan's top pick is vertex pharmaceuticals (VRTX.US).
Vertex pharmaceuticals (Vertex) ranked first on the list of US biotechnology stock selections for 2025 released by jpmorgan.
Vertex Leads J.P. Morgan's Top Biotech Picks List for 2025
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
J.P. Morgan Sticks to Their Buy Rating for Springworks Therapeutics (SWTX)
SpringWorks Therapeutics Initiated at Outperform by Evercore ISI Group
SpringWorks Therapeutics Analyst Ratings